Flat corneas produce unpredictable visual outcomes after PRK

Article

Flat, steep corneas with keratometry values of less than 35 D do not have a predictive effect on the risk of visual acuity loss after myopic photorefractive keratectomy (PRK), claims a paper in the Journal of Refractive Surgery.

Flat, steep corneas with keratometry values of less than 35 D do not have a predictive effect on the risk of visual acuity loss after myopic photorefractive keratectomy (PRK), claims a paper in the Journal of Refractive Surgery.

Dr David Varssano et al., Tel-Aviv Medical Centre, Tel-Aviv, Israel, retrospectively analysed the visual acuity of 5410 eyes that underwent PRK from January 2006 to November 2010. All patients were assessed for the effect of postoperative corneal curvatures on visual outcomes. The main outcome measures were postoperative corrected distance visual acuity (CDVA) and loss of CDVA.

A worse postoperative CDVA was observed in corneas with a flat meridian of less than 35 D and those with a steep meridian of less than 35 D. The worst preoperative CDVA presented in the flatter curvatures in all comparisons conducted for the study. This indicates that calculated meridian curvature had no effect on CDVA loss.

Overall, the team discovered that postoperative corneal keratometry values, especially flat and steep meridians, of less than 35 D did not have a predictive effect on the risk of losing visual acuity after myopic PRK.

For the full abstract please click here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.